A Human NK Cell Activation/Inhibition Threshold Allows Small Changes in the Target Cell Surface Phenotype To Dramatically Alter Susceptibility to NK Cells
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
NK cell activation is negatively regulated by the expression of target cell MHC class I molecules. We show that this relationship is nonlinear due to an NK cell activation/inhibition threshold. Ewing's sarcoma family tumor cell monolayers, which were highly susceptible to NK cells in vitro, developed a highly resistant phenotype when cultured as three-dimensional multicellular tumor spheroid structures. This suggested that tumor architecture is likely to influence the susceptibility to NK cells in vivo. Resistance of the multicellular tumor spheroid was associated with the increased expression of MHC class I molecules and greatly reduced NK cell activation, implying that a threshold of NK cell activation/inhibition had been crossed. Reducing MHC class I expression on Ewing's sarcoma family tumor monolayers did not alter their susceptibility to NK cells, whereas increased expression of MHC class I rendered them resistant and allowed the threshold point to be identified. This threshold, as defined by MHC class I expression, was predictive of the number of NK-resistant target cells within a population. A threshold permits modest changes in the target cell surface phenotype to profoundly alter the susceptibility to NK cells. Whereas this allows for the efficient detection of target cells, it also provides a route for pathogens and tumors to evade NK cell attack.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Further, tumor chips faithfully replicate cancer cell gene expression patterns and have the potential to also model complex cytokine and chemokine signaling networks, which may influence immune cell exhaustion and therapeutic resistance (Powers et al., 2002; Holmes et al., 2011; Marushima et al., 2011; Edmondson et al., 2014; Jensen and Teng, 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Holmes et al., 2011
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
Up on the tightrope: natural killer cell activation and inhibition
Lanier, L. L. (2008) · Nature Immunology · doi:10.1038/ni1581 · Cited by 1,656
Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M., & Koup, R. A. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00265-5 · Cited by 1,587
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
Cited by
Is it time to start transitioning from 2D to 3D cell culture?
Jensen, C., & Teng, Y. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00033 · Cited by 1,640
“This decrease in antigen presentation caused cytotoxic T lymphocyte attacks to become less likely in the cells, making it evident that 3D tumor models resemble the in vivo tumor microenvironment more accurately than 2D tumor models (Holmes et al., 2011).”
BackgroundWilson, E. B., El-Jawhari, J. J., Neilson, A. L., Hall, G. D., Melcher, A. A., Meade, J. L., & Cook, G. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022842 · Cited by 174
Self-citationKailayangiri, S., Altvater, B., Meltzer, J., Pscherer, S., Luecke, A., Dierkes, C., Titze, U., Leuchte, K., Landmeier, S., Hotfilder, M., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.57 · Cited by 142
Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis
Qiao, H., & Tang, T. (2018) · Bone Research · doi:10.1038/s41413-018-0008-9 · Cited by 108
Kailayangiri, S., Altvater, B., Spurny, C., Jamitzky, S., Schelhaas, S., Jacobs, A. H., Wiek, C., Roellecke, K., Hanenberg, H., Hartmann, W., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1250050 · Cited by 104
“downregulate surface MHC class I and thereby fail to bind to inhibitory NK cell receptors, further shifting the balance toward NK cell activation.(5,6) But within a multicellular tumor architecture, EwS cells can develop NK cell resistance,(6) and reports of patients”
BackgroundCytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids
Giannattasio, A., Weil, S., Kloeß, S., Ansari, N., Stelzer, E. H. K., Cerwenka, A., Steinle, A., Koehl, U., & Koch, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1321-y · Cited by 104
“In vitro” 3D models of tumor-immune system interaction
Hirt, C., Papadimitropoulos, A., Mele, V., Muraro, M. G., Mengus, C., Iezzi, G., Terracciano, L., Martín, I., & Spagnoli, G. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.003 · Cited by 103
Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
Colella, G., Fazioli, F., Gallo, M., Chiara, A. D., Apice, G., Ruosi, C., Cimmino, A., & de Nigris, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020615 · Cited by 96
Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT
Holmes, T. D., Wilson, E., Black, E. V. I., Benest, A. V., Vaz, C., Tan, B., Tanavde, V., & Cook, G. P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411072112 · Cited by 87
Self-citationImmunotherapy for small cell lung cancer: mechanisms of resistance
Hamilton, G., & Rath, B. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1592155 · Cited by 87
Cano, F., Bye, H., Duncan, L. M., Buchet-Poyau, K., Billaud, M., Wills, M. R., & Lehner, P. J. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.218 · Cited by 84
A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity
Sherman, H., Gitschier, H. J., & Rossi, A. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00857 · Cited by 84
Christakou, A. E., Ohlin, M., Önfelt, B., & Wiklund, M. (2015) · Lab on a Chip · doi:10.1039/c5lc00436e · Cited by 78
Evert, J. S. H., Cany, J., van den Brand, D., Oudenampsen, M., Brock, R. E., Torensma, R., Bekkers, R. L. M., Jansen, J. H., Massuger, L. F. A. G., & Dolstra, H. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1320630 · Cited by 72
Berghuis, D., Schilham, M. W., Vos, H. I., Santos, S. J., Kloeß, S., Buddingh, E. P., Egeler, R. M., Hogendoorn, P. C. W., & Lankester, A. C. (2012) · Clinical Sarcoma Research · doi:10.1186/2045-3329-2-8 · Cited by 70
Kearney, C. J., Ramsbottom, K. M., Voskoboinik, I., Darcy, P. K., & Oliaro, J. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1196308 · Cited by 70
Lanuza, P. M., Vigueras, A., Oliván, S., Prats, A., Costas, S., Llamazares, G. A., Sánchez‐Martínez, D., Ayuso, J. M., Fernández, L. J., Ochoa, I., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1395123 · Cited by 69
MicroRNA-Deficient NK Cells Exhibit Decreased Survival but Enhanced Function
Sullivan, R. P., Leong, J. W., Schneider, S. E., Keppel, C. R., Germino, E., French, A. R., & Fehniger, T. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102294 · Cited by 67
Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo
Ogbomo, H., Zemp, F. J., Lun, X. Q., Zhang, J., Stack, D., Rahman, M. M., McFadden, G., Mody, C. H., & Forsyth, P. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066825 · Cited by 66
3D tissue-engineered model of Ewing's sarcoma
Lamhamedi-Cherradi, S.-E., Santoro, M., Ramamoorthy, V., Menegaz, B. A., Bartholomeusz, G. A., Iles, L. R., Amin, H. M., Livingston, J. A., Mikos, A. G., & Ludwig, J. A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.012 · Cited by 57
El-Jawhari, J. J., El-Sherbiny, Y. M., Scott, G. B., Morgan, R. S. M., Prestwich, R., Bowles, P. A., Blair, G. E., Tanaka, T., Rabbitts, T. H., Meade, J. L., et al. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2013.11.020 · Cited by 54
Self-citationTargeting NK Cells to Enhance Melanoma Response to Immunotherapies
Lee, H., da Silva, I. P., Palendira, U., Scolyer, R. A., Long, G. V., & Wilmott, J. S. (2021) · Cancers · doi:10.3390/cancers13061363 · Cited by 49
Natural killer cells as a promising therapeutic target for cancer immunotherapy
Kim, N., Lee, H. H., Lee, H.-J., Choi, W. S., Lee, J., & Kim, H. S. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01143-y · Cited by 47
NK Cell Priming From Endogenous Homeostatic Signals Is Modulated by CIS
Delconte, R. B., Guittard, G. C., Goh, W., Hediyeh-zadeh, S., Hennessy, R. J., Rautela, J., Davis, M. J., Souza-Fonseca-Guimarães, F., Nunès, J. A., & Huntington, N. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00075 · Cited by 47
Trypanosoma brucei Co-opts NK Cells to Kill Splenic B2 B Cells
Frenkel, D., Zhang, F., Guirnalda, P. D., Haynes, C., Bockstal, V., Radwanska, M., Magez, S., & Black, S. J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005733 · Cited by 42
Differential MHC class I expression in distinct leukocyte subsets
Greene, J., Wiseman, R. W., Lank, S. M., Bimber, B. N., Karl, J. A., Burwitz, B. J., Lhost, J. J., Hawkins, O. E., Kunstman, K., Broman, K. W., et al. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-39 · Cited by 42
Parsons, M. S., Richard, J., Lee, W. S., Vanderven, H. A., Grant, M. D., Finzi, A., & Kent, S. J. (2016) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0099 · Cited by 41
Klöß, S., Chambron, N., Gardlowski, T., Weil, S., Koch, J., Esser, R., von Strandmann, E. P., Morgan, M. A., Arseniev, L., Seitz, O., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00543 · Cited by 40
Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease
Sterling, K. G., Dodd, G. K., Alhamdi, S., Asimenios, P. G., Dagda, R. K., Meirleir, K. L. D., Hudig, D., & Lombardi, V. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113328 · Cited by 36
Tissue engineered models of healthy and malignant human bone marrow
Chramiec, A. G., & Vunjak‐Novakovic, G. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.04.003 · Cited by 35
Boerman, G. H., Dam, M. M. V. O.-T., Kraal, K. C. J. M., Santos, S. J., Ball, L. M., Lankester, A. C., Schilham, M. W., Egeler, R. M., & van Tol, M. J. D. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1657-9 · Cited by 34
Prospects for NK Cell Therapy of Sarcoma
Lachota, M., Vincenti, M., Winiarska, M., Boye, K., Zagożdżon, R., & Malmberg, K. (2020) · Cancers · doi:10.3390/cancers12123719 · Cited by 29
Almeida, C. R., Ashkenazi, A., Shahaf, G. L., Kaplan, D., Davis, D. M., & Mehr, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024927 · Cited by 29
APLP2 regulates the expression of MHC class I molecules on irradiated Ewing’s sarcoma cells
Peters, H. L., Yan, Y., & Solheim, J. C. (2013) · OncoImmunology · doi:10.4161/onci.26293 · Cited by 26
Bücklein, V., Adunka, T., Mendler, A. N., Issels, R. D., Subklewe, M. S., Schmollinger, J. C., & Noeßner, E. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1178421 · Cited by 24
Sarcoma IL-12 overexpression facilitates NK cell immunomodulation
Rademacher, M. J., Cruz, A., Faber, M. L., Oldham, R. A. A., Wang, D., Medin, J. A., & Schloemer, N. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-87700-2 · Cited by 23
Siddiqui, N., & Hope, J. C. (2012) · European Journal of Immunology · doi:10.1002/eji.201242736 · Cited by 22
In vitro models to study natural killer cell dynamics in the tumor microenvironment
Carannante, V., Wiklund, M., & Önfelt, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1135148 · Cited by 19
Adoptive Cell Therapy for Sarcoma
Mata, M., & Gottschalk, S. M. (2015) · Immunotherapy · doi:10.2217/imt.14.98 · Cited by 15
Microphysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 14
Jeon, S., Kim, H.-K., Kwon, J.-Y., Baek, S., Ri, H.-S., Choi, H., Cho, H.-R., Lee, Y. S., Kim, J., Kim, J., et al. (2020) · Medical Science Monitor · doi:10.12659/msm.926395 · Cited by 14
A 3D co-culture intestinal organoid system for exploring glucose metabolism
Nie, J., Liao, W., Zhang, Z., Zhang, M., Wen, Y., Çapanoğlu, E., Sarker, M. M. R., Zhu, R., & Zhao, C. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.11.021 · Cited by 11
Clinical Applications of Natural Killer Cells
Harada, Y., Teraishi, K., Ishii, M., Ban, H., & Yonemitsu, Y. (2017) · InTech eBooks · doi:10.5772/intechopen.68991 · Cited by 6
A new approach to assess drug sensitivity in cells for novel drug discovery
Mazzarella, L., & Curigliano, G. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1437136 · Cited by 6
Natural Killer Cell and Cancer Immunotherapy
Kim, H. S. (2013) · Hanyang Medical Reviews · doi:10.7599/hmr.2013.33.1.59 · Cited by 4
Dual effects of natural killer cells in transplantation for leukemia
Arima, N. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103206 · Cited by 4
Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma
Barr, T., Jennings, V. A., Roundhill, E. A., Baugh, R. T., Yamrali, M., Owston, H. E., McGonagle, D., Giannoudis, P. V., Caplen, N. J., Khan, J. I., et al. (2025) · Cancers · doi:10.3390/cancers17203319 · Cited by 3
Self-citationMODELING NATURAL KILLER CELL REPERTOIRE DEVELOPMENT AND ACTIVATION DYNAMICS
Sternberg‐Simon, M., & Mehr, R. (2013) · International Symposium on Mathematical and Computational Biology (BIOMAT) · doi:10.1142/9789814520829_0008 · Cited by 1
Close, H. J. (2016) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Maggs, L. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
The Roles of miR-155 and miR-15/16 in Natural Killer Cell Function and Maturation
Sullivan, R. P. (2014) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7g15xv6
Development of model system to study NC cell hyporesponsiveness
Romera‐Cárdenas, G. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Activation of Natural Killer Cells by Oncolytic Viruses
Wantoch, M. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Adenovirus vectors for manipulating human immune cells
Drake, S. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Natural killer cells and their possible therapeutic role in ovarian cancer.
Evert, J. (2020) · Radboud Repository (Radboud University)
Waitszies, D. (2021) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.27881
Influencia de la necrosis tumoral en neuroblastoma sobre la migración de células NK.
Pesini, C., Jimeno, J. P., & Buerba, E. M. G. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
L’ingénierie des cellules NK entant que nouvelle immunothérapie ciblée contre le rhabdomyosarcome
Benhaddou, S. (2023) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/26882
Lanuza Morte, P. M., Jimeno, J. P., & Cabrero, M. A. A. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Holmes, T. D., El-Sherbiny, Y. M., Davison, A., Clough, S. L., Blair, G. E., & Cook, G. P.
- Affiliations
- University of Leeds (GB)
- Corresponding author
- Davison, Adam
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-01
- Volume
- 186
- Issue
- 3
- Pages
- 1538-1545
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2095690828
- Cited by
- 52
- References
- 47
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 2 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 5
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NK cell activation, NK cell inhibition, MHC class I, tumor spheroids, tumor architecture, NK cell resistance, NK cell evasion, NK cell cytotoxicity
- MeSH terms
- Cell Membrane, Cytotoxicity Tests, Immunologic, HeLa Cells, Humans, Immunity, Innate, Killer Cells, Natural, Lymphocyte Activation, Sarcoma, Ewing, Translocation, Genetic, Tumor Cells, Cultured, Immunophenotyping, Spheroids, Cellular, Tumor Escape, K562 Cells, Genetic Predisposition to Disease, Cell Line, Tumor, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.